- Feedback
- 18 December 2025 14:22:11
Source: Sharecast
The AIM-traded clinical infrastructure specialist said revenue for the six months ended 30 November was expected to be about £0.4m, unchanged from the same period a year earlier.
It said its cash outlook remained in line with expectations, leaving it sufficiently funded into mid-2027.
Feedback said conditions across the NHS had started to stabilise following disruption and uncertainty last year, with increased attention from policymakers and NHS management on the role of technology and digitisation in reducing waiting times and supporting a shift towards neighbourhood healthcare.
That had been underpinned by commitments to increase NHS technology spending.
The group said its Bleepa platform was well positioned to benefit from the move from analogue to digital workflows and from efforts to improve integration between hospital and community care, while also supporting reductions in waiting lists.
As last year’s disruption eased and the policy focus on technology strengthened, management said it expected sales momentum to build around the next tax year, with the business positioned to scale rapidly.
“The 10-year plan and direction of travel of the NHS are clearly aligned with the solutions we provide,” said chief executive Tom Oakley.
“Spending review funding is due to be released to the NHS frontline for 2026-2027, and we believe that this combined with an increasing recognition of the role of technology in healthcare will drive a new phase of commercialisation for Feedback.”
Reporting by Josh White for Sharecast.com.